Selective AKR1C3 inhibitors do not recapitulate the anti-leukaemic activities of the pan-AKR1C inhibitor medroxyprogesterone acetate
F Khanim , N Davies , P Veliça , R Hayden
British Journal of Cancer 110 ( 6) 1506 -1516
19
2014
Modified Hypoxia-Inducible Factor Expression in CD8+ T Cells Increases Antitumor Efficacy
David Bargiela , David Bargiela , Iosifina Petrina Foskolou , Iosifina Petrina Foskolou
Cancer immunology research 9 ( 4) 401 -414
2
2021
Oxygen-Mediated Suppression of CD8+ T Cell Proliferation by Macrophages: Role of Pharmacological Inhibitors of HIF Degradation.
Helene Rundqvist , Randall S. Johnson , Milos Gojkovic , Pedro Veliça
Frontiers in Immunology 12 633586
2021
Memory lapses in graft‐versus‐host disease
Barry Flutter , Pedro Veliça , Ronjon Chakraverty
European Journal of Immunology 41 ( 9) 2530 -2534
2011
Lack of functional and expression homology between human and mouse aldo-keto reductase 1C enzymes: implications for modelling human cancers
Pedro Veliça , Nicholas J Davies , Pedro P Rocha , Heinrich Schrewe
Molecular Cancer 8 ( 1) 121 -121
48
2009
Expression of a dominant T-cell receptor can reduce toxicity and enhance tumor protection of allogeneic T-cell therapy
Angelika Holler , Mathias Zech , Sara Ghorashian , Rebecca Pike
Haematologica 101 ( 4) 482 -490
2
2016
Cytotoxic T-cells mediate exercise-induced reductions in tumor growth.
Helene Rundqvist , Pedro Veliça , Laura Barbieri , Paulo A Gameiro
eLife 9
76
2020
Prostaglandin D2 inhibits C2C12 myogenesis
Pedro Veliça , Farhat L. Khanim , Chris M. Bunce
Molecular and Cellular Endocrinology 319 ( 1) 71 -78
18
2010
Deregulated hypoxic response in myeloid cells: A model for high-altitude pulmonary oedema (HAPE).
Milos Gojkovic , Gabriella S. Darmasaputra , Pedro Veliça , Helene Rundqvist
Acta Physiologica 229 ( 2)
3
2020
Response to Swenson and Bärtsch.
Milos Gojkovic , Pedro Veliça , Helene Rundqvist , Randall S. Johnson
Acta Physiologica 231 ( 1)
2021
S -2-hydroxyglutarate regulates CD8 + T-lymphocyte fate
Petros A. Tyrakis , Asis Palazon , David Macias , Kian. L. Lee
Nature 540 ( 7632) 236 -241
298
2016
Genetic Regulation of Fate Decisions in Therapeutic T Cells to Enhance Tumor Protection and Memory Formation
Pedro Veliça , Mathias Zech , Sian Henson , Angelika Holler
Cancer Research 75 ( 13) 2641 -2652
17
2015
An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression
Asis Palazon , Petros A. Tyrakis , David Macias , Pedro Veliça
Cancer Cell 32 ( 5) 5 -683
131
2017
Abstract C10: The role of FIH in macrophage function
Milos Gojkovic , Helene Rundqvist , Pedro Veliça , Randall S. Johnson
Cancer Research 76
2016
CD8 T Cell Tolerance to a Tumor-Associated Self-Antigen Is Reversed by CD4 T Cells Engineered To Express the Same T Cell Receptor
Sara Ghorashian , Pedro Veliça , Ignatius Chua , Anne-Marie McNicol
Journal of Immunology 194 ( 3) 1080 -1089
21
2015
A quick, simple and unbiased method to quantify C2C12 myogenic differentiation
Pedro Veliça , Chris M. Bunce
Muscle & Nerve 44 ( 3) 366 -370
45
2011
Prostaglandins in muscle regeneration
Pedro Veliça , Chris M. Bunce
Journal of Muscle Research and Cell Motility 29 ( 6) 163 -167
13
2008
Lactate potentiates differentiation and expansion of cytotoxic T cells
Helene Rundqvist , Pedro Veliça , Laura Barbieri , Paulo A. Gameiro
bioRxiv 571745
4
2019
Vitamin B6 metabolism determines T cell anti-tumor responses
David Bargiela , Pedro P Cunha , Pedro Veliça , Iosifina P Foskolou
Frontiers in Immunology 13 837669 -837669
15
2022
Lactate exposure shapes the metabolic and transcriptomic profile of CD8+ T cells
Laura Barbieri , Pedro Veliça , Paulo A Gameiro , Pedro P Cunha
Frontiers in Immunology 14 1101433 -1101433
9
2023